Fintel reports that on February 6, 2025, William Blair initiated coverage of Mersana Therapeutics (NasdaqGS:MRSN) with a ...

Fintel reports that on February 5, 2025, William Blair upgraded their outlook for Tempur Sealy International (NYSE:TPX) from ...

Research analysts at William Blair issued their Q2 2026 earnings per share (EPS) estimates for Twist Bioscience in a report ...

Equities researchers at William Blair cut their Q3 2025 earnings estimates for Sera Prognostics in a report released on Monday, February 3rd. William Blair analyst A. Brackmann now expects that the ...

William Blair initiated coverage of Mersana Therapeutics (MRSN) with an Outperform rating.Maximize Your Portfolio with Data Driven ...

CHICAGO (WLS) -- Portillo's beat McDonald's for best value in fast food, according to a new consumer survey from William ...

William Blair International Growth Fund earns an Average Process Pillar rating. The predominant contributor to the rating is the fund's impressive long-term risk-adjusted performance. This can be ...

William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The largest contributor to the rating is the stability of the management team. Specifically, the fund has not seen a ...

Stephanie Braming, global head of William Blair Investment Management, plans to retire in the fourth quarter, a news release ...